Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phaeochromocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00458952
What this trial is testing

Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma

Who this might be right for
PheochromocytomaParaganglioma
Molecular Insight Pharmaceuticals, Inc. 24
Not applicableStudy completedNCT00001229
What this trial is testing

Diagnosis and Treatment of Pheochromocytoma

Who this might be right for
Pheochromocytoma
National Heart, Lung, and Blood Institute (NHLBI) 240
Not applicableLooking for participantsNCT07195500
What this trial is testing

Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma

Who this might be right for
NeuroblastomaPheochromocytomaParaganglioma
Nanjing First Hospital, Nanjing Medical University 30
Not applicableStudy completedNCT00590096
What this trial is testing

I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma

Who this might be right for
NeuroblastomaPheochromocytoma
Children's Hospital Medical Center, Cincinnati 1,380
Very early researchLooking for participantsNCT05069220
What this trial is testing

18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor

Who this might be right for
Neuroendocrine TumorNeuroblastomaPheochromocytoma+1 more
Peking Union Medical College Hospital 150
Not applicableEnrolling By InvitationNCT06870396
What this trial is testing

National Study of Adrenal Tumours

Who this might be right for
Pheochromocytoma and Paraganglioma (PPGL)Adrenocorticol Cancer (ACC)Adrenal Tumours
Society for Endocrinology 300
Early research (Phase 1)Looking for participantsNCT04119024
What this trial is testing

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more
Anusha Kalbasi 18
Early research (Phase 1)Study completedNCT00655655
What this trial is testing

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+17 more
Mayo Clinic 96
Not applicableActive Not RecruitingNCT01660984
What this trial is testing

Natural History Study of Children and Adults With Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer
National Cancer Institute (NCI) 105
Not applicableEnded earlyNCT05456997
What this trial is testing

Metabolic Myopathy in Endocrinopathy

Who this might be right for
Cushing SyndromePheochromocytomaConns Syndrome+1 more
Barts & The London NHS Trust 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06121271
What this trial is testing

Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications

Who this might be right for
Bronchial and Thymic Neuroendocrine TumourParaganglioma/ PhaeochromocytomaMedullary Thyroid Carcinoma+1 more
University College, London 110
Testing effectiveness (Phase 2)Study completedNCT01371201
What this trial is testing

First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma

Who this might be right for
Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL)
Gustave Roussy, Cancer Campus, Grand Paris 78
Not applicableEnded earlyNCT00911729
What this trial is testing

Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma

Who this might be right for
PheochromocytomaParaganglioma
Molecular Insight Pharmaceuticals, Inc. 24
Not applicableStudy completedNCT01850888
What this trial is testing

MIBG for Refractory Neuroblastoma and Pheochromocytoma

Who this might be right for
Relapsed NeuroblastomaMetastatic Pheochromocytoma
Masonic Cancer Center, University of Minnesota 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743138
What this trial is testing

STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL)

Who this might be right for
Adrenocortical CarcinomaPheochromocytomaParaganglioma
M.D. Anderson Cancer Center 20
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03946527
What this trial is testing

LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)

Who this might be right for
ParagangliomaPheochromocytoma
Antonio Fojo 10
Not applicableUnknownNCT06229405
What this trial is testing

Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data

Who this might be right for
Adrenal TumorPrimary AldosteronismCushing Syndrome+2 more
Seoul National University Hospital 8,200
Testing effectiveness (Phase 2)Study completedNCT01635907
What this trial is testing

Dovitinib in Neuroendocrine Tumors

Who this might be right for
Advanced Metastatic ParagangliomaAdvanced Metastatic PheochromocytomaRecurrent Paraganglioma+3 more
Abramson Cancer Center at Penn Medicine 8
Testing effectiveness (Phase 2)Looking for participantsNCT06607692
What this trial is testing

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Who this might be right for
Solid Tumor CancerMedulloblastomaHigh Risk Neuroblastoma+19 more
Fundación de investigación HM 25
Next Page